Serotonin, histamine and platelets in vascular disease with special reference to peripheral vascular disease.
Cardiovascular disease is a major cause of death. There is evidence that this disease is predicted and its progression influenced by various factors (e.g. hyperlipidaemia). In this review, we consider aspects of platelet structure and function which may explain how this cell type contributes to the pathogenesis of vascular disease. The platelet also contains bioamines (serotonin, 5-HT; histamine) which are potent vasoactive substances. Studies involving patients with peripheral vascular disease (PVD) where abnormalities in platelet function (platelet aggregation and platelet shape change) and in bioamine status (vascular, platelet and plasma bioamine concentrations) are reviewed. We also discuss how platelet activation (in vitro) and plasma lipids influence intraplatelet bioamine status. Finally, we report in vitro evidence of the effect of two drugs prescribed to PVD patients: aspirin and naftidrofuryl. Aspirin is an ineffective inhibitor of 5-HT-induced whole blood platelet aggregation whereas naftidrofuryl is effective in the presence or absence of aspirin. By identifying and altering the factors which contribute to the pathogenesis of atherosclerosis we will be better equipped to prevent, reverse or retard this process.
Barradas
M A
MA
Department of Chemical Pathology and Human Metabolism, Royal Free Hospital School of Medicine, University of London, United Kingdom.
Mikhailidis
D P
DP
D000818:Animals; D001161:Arteriosclerosis / Q000097:blood / Q000209:etiology; D001679:Biogenic Amines / Q000097:blood; D001792:Blood Platelets / Q000166:cytology* / Q000502:physiology; D006632:Histamine / Q000097:blood*; D006801:Humans; D008055:Lipids / Q000097:blood; D016491:Peripheral Vascular Diseases / Q000097:blood* / Q000209:etiology; D010974:Platelet Aggregation / Q000187:drug effects; D012701:Serotonin / Q000097:blood*
D001679:Biogenic Amines; D008055:Lipids; D012701:Serotonin; D006632:Histamine